Memphis Pharmaceuticals (MPCI.CA) Company’s Reply to the Report of the Central Auditing Organization
Company Name : Memphis Pharmaceuticals
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The company’s response to the report of the Central Auditing Organization on the financial statements for the financial period ending on 09/30/2021
Company's Reply (357 KB)
ISIN Code : EGS38351C010
Reuters Code : MPCI.CA
Content :
The company’s response to the report of the Central Auditing Organization on the financial statements for the financial period ending on 09/30/2021
Company's Reply (357 KB)
Comments